OrbusNeich granted stent patent; expands Bos Sci case
OrbusNeich Medical, a developer and marketer of medical devices for the treatment of cardiovascular diseases, was granted U.S. Patent No. 7,682,384 B2, entitled ‘Stent with Helical Elements,’ relating to an expandable stent comprised of a plurality of helical segments. The Hong Kong-based company has identified unlicensed use by Boston Scientific of certain technologies protected under U.S. Patent No. 7,682,384 B2.
OrbusNeich said it believes that its previously announced infringement claims against Boston Scientific in the U.S. District Court for the District of Massachusetts, specifically related to Boston Scientific's Liberte and Taxus Liberte stents, could be expanded to include the newly granted patent. As a result, the company today filed with the court a motion to amend its existing complaint against the Natick, Mass.-based Boston Scientific.
"We are committed to taking all appropriate actions to ensure that our proprietary technology and extensive research and development efforts are to the benefit of OrbusNeich's investors, employees and physician customers and their patients – not those of competitors," said Al Novak, president and CEO of OrbusNeich.
OrbusNeich said it believes that its previously announced infringement claims against Boston Scientific in the U.S. District Court for the District of Massachusetts, specifically related to Boston Scientific's Liberte and Taxus Liberte stents, could be expanded to include the newly granted patent. As a result, the company today filed with the court a motion to amend its existing complaint against the Natick, Mass.-based Boston Scientific.
"We are committed to taking all appropriate actions to ensure that our proprietary technology and extensive research and development efforts are to the benefit of OrbusNeich's investors, employees and physician customers and their patients – not those of competitors," said Al Novak, president and CEO of OrbusNeich.